ConductScience.org, home

Paper39192059

Development of 52Mn Labeled Trastuzumab for Extended Time Point PET Imaging of HER2.

Omweri JM and 6 others. Mol Imaging Biol, 2024. Cited by 9 papers, by iCite.

Cite this record

ConductScience Library. Development of 52Mn Labeled Trastuzumab for Extended Time Point PET Imaging of HER2. Papers, record 39192059. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39192059

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Development of 52Mn Labeled Trastuzumab for Extended Time Point PET Imaging of HER2.
PubMed
Journal
Mol Imaging Biol
PubMed
Year
2024
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural
PubMed
Citations, by iCite
9
iCite
Relative citation ratio, by iCite
1.87, provisional
iCite
Revised in PubMed
2026-09-23
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Omweri JMJames M
2Saini SShefali
3Houson HAHailey A
4Tekin VVolkan
5Pyles JMJennifer M
6Parker CCCandace C
7Lapi SESuzanne Ehttps://orcid.org/0000-0003-0090-0191

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
TrastuzumabMajor topic
Positron-Emission TomographyMajor topic
Erb-b2 Receptor Tyrosine KinasesMajor topic
ManganeseMajor topic
Animals
Humans
Cell Line, Tumor
Female
Tissue Distribution
Mice
Mice, Nude
Isotope Labeling

Source PubMed

Download CSV of topics

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
P30 CA013148NCI NIH HHSUnited StatesP30CA013148PubMedNIH RePORTER
DESC0021269Office of SciencePubMedPubMed

Download CSV of grants

References55

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
12887254989Zr-Trastuzumab PET/CT for Detection of Human Epidermal Growth Factor Receptor 2-Positive Metastases in Patients With Human Epidermal Growth Factor Receptor 2-Negative Primary Breast Cancer.Clin Nucl Med2017https://conductscience.org/library/papers/28872549PubMed
227151988Detection of HER2-Positive Metastases in Patients with HER2-Negative Primary Breast Cancer Using 89Zr-Trastuzumab PET/CT.J Nucl Med2016https://conductscience.org/library/papers/27151988PubMed
338154167Chelation chemistry of manganese-52 for PET imaging applications.Nucl Med Biol2024https://conductscience.org/library/papers/38154167PubMed
433948375ImmunoPET of the differential expression of CD146 in breast cancer.Am J Cancer Res2021https://conductscience.org/library/papers/33948375PubMed
522998840PET imaging with ⁸⁹Zr: from radiochemistry to the clinic.Nucl Med Biol2013https://conductscience.org/library/papers/22998840PubMed
637385676Immuno-PET Detects Antibody-Drug Potency on Coadministration with Statins.J Nucl Med2023https://conductscience.org/library/papers/37385676PubMed
731562219Total-Body PET and Highly Stable Chelators Together Enable Meaningful 89Zr-Antibody PET Studies up to 30 Days After Injection.J Nucl Med2020https://conductscience.org/library/papers/31562219PubMed
815289297Preclinical characterisation of 111In-DTPA-trastuzumab.Br J Pharmacol2004https://conductscience.org/library/papers/15289297PubMed
934857660Use of 64Cu-DOTA-Trastuzumab PET to Predict Response and Outcome of Patients Receiving Trastuzumab Emtansine for Metastatic Breast Cancer: A Pilot Study.J Nucl Med2022https://conductscience.org/library/papers/34857660PubMed
1025058168Evaluation of (89)Zr-pertuzumab in Breast cancer xenografts.Mol Pharm2014https://conductscience.org/library/papers/25058168PubMed
112066037689Zr-DFO-J591 for immunoPET of prostate-specific membrane antigen expression in vivo.J Nucl Med2010https://conductscience.org/library/papers/20660376PubMed
1230676778Imaging of HER2 with [89Zr]pertuzumab in Response to T-DM1 Therapy.Cancer Biother Radiopharm2019https://conductscience.org/library/papers/30676778PubMed
1330151358Effect of the Nature of Donor Atoms on the Thermodynamic, Kinetic and Relaxation Properties of Mn(II) Complexes Formed With Some Trisubstituted 12-Membered Macrocyclic Ligands.Front Chem2018https://conductscience.org/library/papers/30151358PubMed
1438733556Good practices for 89Zr radiopharmaceutical production and quality control.EJNMMI Radiopharm Chem2024https://conductscience.org/library/papers/38733556PubMed
1537552575Evaluation of [89Zr]Zr-DFO-2Rs15d Nanobody for Imaging of HER2-Positive Breast Cancer.Mol Pharm2023https://conductscience.org/library/papers/37552575PubMed
1620111600Measuring the pharmacodynamic effects of a novel Hsp90 inhibitor on HER2/neu expression in mice using Zr-DFO-trastuzumab.PLoS One2010https://conductscience.org/library/papers/20111600PubMed
1729357745Targeting HER2 in Nuclear Medicine for Imaging and Therapy.Mol Imaging2018https://conductscience.org/library/papers/29357745PubMed
1826598545Molecular imaging as a tool to investigate heterogeneity of advanced HER2-positive breast cancer and to predict patient outcome under trastuzumab emtansine (T-DM1): the ZEPHIR trial.Ann Oncol2016https://conductscience.org/library/papers/26598545PubMed
1931548601HER2-targeted therapies - a role beyond breast cancer.Nat Rev Clin Oncol2020https://conductscience.org/library/papers/31548601PubMed
2023736785(89)Zr, a radiometal nuclide with high potential for molecular imaging with PET: chemistry, applications and remaining challenges.Molecules2013https://conductscience.org/library/papers/23736785PubMed

See all 55 referencesDownload CSV of references

Cited by7

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 9 citations.

PMIDTitleJournalYearIn PapersSource
42708148Radiocopper in BCMA-targeted immunotheranostics of myeloma.Theranostics2026https://conductscience.org/library/papers/42708148PubMed
42356507Emerging Theranostic Radiometals (149Tb, 44Sc, 52Mn, 203Pb, 55Co)-Decay Diversity, Production Landscape, and Translational Imaging.Pharmaceuticals (Basel)2026https://conductscience.org/library/papers/42356507PubMed
42120551Tellurium-118 as a novel radionuclide for long-term positron emission tomography.Sci Rep2026https://conductscience.org/library/papers/42120551PubMed
41901362Enhanced Tumor-to-Background Contrast with [52Mn]Mn-BPPA-Bevacizumab VEGF-Targeted Immuno-PET in Cervical Cancer.Pharmaceuticals (Basel)2026https://conductscience.org/library/papers/41901362PubMed
40365451HER2 expression in different cell lines at different inoculation sites assessed by [52Mn]Mn-DOTAGA(anhydride)-trastuzumab.Pathol Oncol Res2025https://conductscience.org/library/papers/40365451PubMed
40131608Highlight selection of radiochemistry and radiopharmacy developments by editorial board.EJNMMI Radiopharm Chem2025https://conductscience.org/library/papers/40131608PubMed
39768978Novel Molecular Classification of Breast Cancer with PET Imaging.Medicina (Kaunas)2024https://conductscience.org/library/papers/39768978PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
ERBB22064PubTator's text mininghttps://conductscience.org/library/genes/2064

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39192059

GET https://conductscience.org/api/papers/v1/39192059/references?page=2